Author

N. Eberhardt

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 3 Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Assay:metabolomics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Anastasia· 1 shared A. Rapkiewicz· 1 shared A. V. Guillen· 1 shared A.-K. Mittler· 1 shared B. Cilhoroz· 1 shared C. A. Galvan· 1 shared C. Giannarelli· 1 shared C. Rockman· 1 shared

Activity by Year

2020-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. Anastasia

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

MICROBIOTA AT THE CROSS ROAD OF DIET AND HEALTH: HOW DIETARY FATS SHAPE BACTERIAL LAND-SCAPE AND INFLUENCE GLOBAL HEALTH

N. D. Portela, N. Eberhardt, G. Bergero, Y. L. Mazzocco, M. P. Aoki, C. A. Galvan, R. C. Cano, S. A. Pesoa

This study investigates how omega-3 fatty acid doses affect gut microbiota composition, immune cells, and metabolic biomarkers in mice fed high-fat diets.

bioRxiv · Jul 8, 2024 · PreprintMicrobiology

SARS-CoV-2 infection triggers pro-atherogenic inflammatory 1 responses in human coronary vessels

N. Eberhardt, M. G. Noval, R. Kaur, S. Sajja, L. Amadori, D. Das, B. Cilhoroz, O. J. Stewart, D. M. Fernandez, R. Shamailova, A. V. Guillen, S. Jangra, M. Schotsaert, M. Gildea, J. D. Newman, , C. Giannarelli

This study shows SARS-CoV-2 infects macrophages in coronary atherosclerotic lesions, causing inflammation that may increase cardiovascular risk.

bioRxiv · Aug 14, 2023Immunology

Pharmacological targeting of host chaperones protects from pertussis toxin in vitro and in vivo

K. Ernst, A.-K. Mittler, V. Winkelmann, N. Eberhardt, A. Anastasia, M. Sonnabend, R. Lochbaum, J. Wirsching, C. Skerry, N. H. Carbonetti, M. Frick, H. Barth

The paper investigates how host chaperones facilitate pertussis toxin uptake and shows that pharmacological inhibition of these chaperones protects cells from PT toxicity.

bioRxiv · Sep 24, 2020Pharmacology & Toxicology